IBDEI2FU ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41354,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,41354,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,41355,0)
 ;;=D47.Z9^^159^2004^173
 ;;^UTILITY(U,$J,358.3,41355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41355,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,41355,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,41355,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,41356,0)
 ;;=D05.82^^159^2004^34
 ;;^UTILITY(U,$J,358.3,41356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41356,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,41356,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,41356,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,41357,0)
 ;;=D05.81^^159^2004^36
 ;;^UTILITY(U,$J,358.3,41357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41357,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,41357,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,41357,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,41358,0)
 ;;=D05.80^^159^2004^38
 ;;^UTILITY(U,$J,358.3,41358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41358,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,41358,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,41358,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,41359,0)
 ;;=D56.8^^159^2004^186
 ;;^UTILITY(U,$J,358.3,41359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41359,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,41359,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,41359,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,41360,0)
 ;;=C82.89^^159^2004^76
 ;;^UTILITY(U,$J,358.3,41360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41360,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,41360,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,41360,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,41361,0)
 ;;=D51.8^^159^2004^193
 ;;^UTILITY(U,$J,358.3,41361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41361,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,41361,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,41361,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,41362,0)
 ;;=I80.9^^159^2004^178
 ;;^UTILITY(U,$J,358.3,41362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41362,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,41362,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,41362,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,41363,0)
 ;;=D45.^^159^2004^179
 ;;^UTILITY(U,$J,358.3,41363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41363,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,41363,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,41363,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,41364,0)
 ;;=C77.3^^159^2004^109
 ;;^UTILITY(U,$J,358.3,41364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41364,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,41364,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,41364,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,41365,0)
 ;;=C77.2^^159^2004^125
 ;;^UTILITY(U,$J,358.3,41365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41365,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,41365,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,41365,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,41366,0)
 ;;=C77.1^^159^2004^126
 ;;^UTILITY(U,$J,358.3,41366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41366,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,41366,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,41366,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,41367,0)
 ;;=C77.0^^159^2004^142
